Published in J Biol Chem on August 21, 2003
Targeting of calcium/calmodulin-dependent protein kinase II. Biochem J (2004) 2.08
The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Pharmacol Rev (2005) 1.96
NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. J Neurosci (2007) 1.95
p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J (2005) 1.90
Synaptic plasticity and phosphorylation. Pharmacol Ther (2006) 1.58
SAP97 and CASK mediate sorting of NMDA receptors through a previously unknown secretory pathway. Nat Neurosci (2009) 1.40
A dynamic view of domain-motif interactions. PLoS Comput Biol (2012) 0.98
alpha-Isoform of calcium-calmodulin-dependent protein kinase II and postsynaptic density protein 95 differentially regulate synaptic expression of NR2A- and NR2B-containing N-methyl-d-aspartate receptors in hippocampus. Neuroscience (2007) 0.96
High-throughput analysis of peptide-binding modules. Proteomics (2012) 0.93
Interaction of the RhoA exchange factor Net1 with discs large homolog 1 protects it from proteasome-mediated degradation and potentiates Net1 activity. J Biol Chem (2009) 0.86
Glutamate receptors localize postsynaptically at neuromuscular junctions in mice. Muscle Nerve (2009) 0.84
CASK regulates SAP97 conformation and its interactions with AMPA and NMDA receptors. J Neurosci (2013) 0.83
Interactions and phosphorylation of postsynaptic density 93 (PSD-93) by extracellular signal-regulated kinase (ERK). Brain Res (2012) 0.82
Differential regulation of two isoforms of the glial glutamate transporter EAAT2 by DLG1 and CaMKII. J Neurosci (2015) 0.80
Immunogold electron microscopic evidence of differential regulation of GluN1, GluN2A, and GluN2B, NMDA-type glutamate receptor subunits in rat hippocampal CA1 synapses during benzodiazepine withdrawal. J Comp Neurol (2010) 0.79
A Critical Role for the GluA1 Accessory Protein, SAP97, in Cocaine Seeking. Neuropsychopharmacology (2015) 0.79
Loss of F-box only protein 2 (Fbxo2) disrupts levels and localization of select NMDA receptor subunits, and promotes aberrant synaptic connectivity. J Neurosci (2015) 0.78
DlgS97/SAP97, a neuronal isoform of discs large, regulates ethanol tolerance. PLoS One (2012) 0.77
ER to synapse trafficking of NMDA receptors. Front Cell Neurosci (2014) 0.77
Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex. Nat Commun (2015) 0.76
Fingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal Neurons. Sci Rep (2017) 0.75
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci (2013) 4.35
Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem (2002) 1.67
In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons. Nat Neurosci (2013) 1.64
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J Biol Chem (2003) 1.55
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. Arch Neurol (2007) 1.42
Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area. Nat Neurosci (2011) 1.38
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci (2006) 1.34
[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med (2002) 1.26
Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis. J Neurosci (2010) 1.25
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization. Mol Pharmacol (2008) 1.24
Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci (2007) 1.23
Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain (2008) 1.19
Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation. PLoS One (2010) 1.17
Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. J Neurosci (2009) 1.16
Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J Biol Chem (2006) 1.16
New targets for pharmacological intervention in the glutamatergic synapse. Eur J Pharmacol (2006) 1.15
Calcium/calmodulin-dependent protein kinase II phosphorylation drives synapse-associated protein 97 into spines. J Biol Chem (2004) 1.13
AMPA receptors and stargazin-like transmembrane AMPA receptor-regulatory proteins mediate hippocampal kainate neurotoxicity. Proc Natl Acad Sci U S A (2007) 1.11
Neonatal exposure to brominated flame retardant BDE-47 reduces long-term potentiation and postsynaptic protein levels in mouse hippocampus. Environ Health Perspect (2007) 1.09
Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease. J Neurochem (2011) 1.09
Nuclear calcium signaling in spinal neurons drives a genomic program required for persistent inflammatory pain. Neuron (2013) 1.09
Cocaine-evoked synaptic plasticity: a key to addiction? Nat Neurosci (2008) 1.07
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci (2004) 1.06
The NMDA/D1 receptor complex as a new target in drug development. Curr Top Med Chem (2006) 1.04
Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol Dis (2011) 1.04
Calcium-calmodulin-dependent protein kinase II phosphorylation modulates PSD-95 binding to NMDA receptors. Eur J Neurosci (2006) 1.01
Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets. Exp Gerontol (2009) 0.99
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. J Neurochem (2004) 0.99
Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage. J Neurosci (2010) 0.98
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function. Curr Opin Pharmacol (2009) 0.98
Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation. J Neuroinflammation (2011) 0.98
Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias. Neurobiol Aging (2011) 0.97
Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. J Neurosci (2010) 0.97
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. Brain (2012) 0.96
Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol Dis (2013) 0.96
From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease. Brain Res (2012) 0.95
Expression of cocaine-evoked synaptic plasticity by GluN3A-containing NMDA receptors. Neuron (2013) 0.95
NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke (2006) 0.95
Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat. Mol Pharmacol (2005) 0.95
SAP97 directs the localization of Kv4.2 to spines in hippocampal neurons: regulation by CaMKII. J Biol Chem (2007) 0.95
Synaptic dysfunction in Alzheimer's disease. Adv Exp Med Biol (2012) 0.94
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation. FASEB J (2002) 0.94
NMDA receptor composition differs among anatomically diverse malformations of cortical development. J Neuropathol Exp Neurol (2006) 0.94
Lack of PSD-95 drives hippocampal neuronal cell death through activation of an alpha CaMKII transduction pathway. Eur J Neurosci (2002) 0.93
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation. J Neurochem (2008) 0.93
Importance of the inverted control in measuring holistic face processing with the composite effect and part-whole effect. Front Psychol (2013) 0.93
Long-lasting effects of neonatal dexamethasone treatment on spatial learning and hippocampal synaptic plasticity: involvement of the NMDA receptor complex. FASEB J (2003) 0.92
Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease. J Clin Invest (2013) 0.91
Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB. Mol Endocrinol (2002) 0.91
BDNF genetic variations increase the risk of Alzheimer's disease-related depression. J Alzheimers Dis (2009) 0.91
An arginine stretch limits ADAM10 exit from the endoplasmic reticulum. J Biol Chem (2010) 0.90
Amyloid flirting with synaptic failure: towards a comprehensive view of Alzheimer's disease pathogenesis. Eur J Pharmacol (2008) 0.90
Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci (2002) 0.90
Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series. Neurogenetics (2008) 0.90
Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients. Neurobiol Aging (2005) 0.90
Linking supply to demand: the neuronal monocarboxylate transporter MCT2 and the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid receptor GluR2/3 subunit are associated in a common trafficking process. Eur J Neurosci (2009) 0.89
Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts. Neurobiol Dis (2004) 0.89
Aberrant A2A receptor function in peripheral blood cells in Huntington's disease. FASEB J (2003) 0.89
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. Sci Rep (2013) 0.88
Nuclear calcium signaling regulates nuclear export of a subset of class IIa histone deacetylases following synaptic activity. J Biol Chem (2013) 0.88
Inverse association between dietary vitamin D and risk of cutaneous melanoma in a northern Italy population. Nutr Cancer (2011) 0.87
α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease. Brain Res (2011) 0.87
A key role for caspase-2 and caspase-3 in the apoptosis induced by 2-chloro-2'-deoxy-adenosine (cladribine) and 2-chloro-adenosine in human astrocytoma cells. Mol Pharmacol (2003) 0.87
Nerve growth factor signaling in prostate health and disease. Growth Factors (2010) 0.87
Identification and characterization of two nuclear factor-kappaB sites in the regulatory region of the dopamine D2 receptor. Endocrinology (2007) 0.87
Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease. Brain (2010) 0.87
Predicting Alzheimer dementia in mild cognitive impairment patients. Are biomarkers useful? Eur J Pharmacol (2006) 0.87
Combined biomarkers for early Alzheimer disease diagnosis. Curr Med Chem (2007) 0.86
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch Neurol (2002) 0.86
A robust method of measuring other-race and other-ethnicity effects: the Cambridge Face Memory Test format. PLoS One (2012) 0.86
Presenilin 2 mutations alter cystatin C trafficking in mouse primary neurons. Neurobiol Aging (2006) 0.86
Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease. Am J Geriatr Psychiatry (2006) 0.86
SAP97-mediated local trafficking is altered in Alzheimer disease patients' hippocampus. Neurobiol Aging (2010) 0.86
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling. Mol Pharmacol (2013) 0.85
SNAP-25 regulates spine formation through postsynaptic binding to p140Cap. Nat Commun (2013) 0.85
Molecular rationale for the pharmacological treatment of Alzheimer's disease. Drugs Aging (2005) 0.85
Neurogenesis in cerebral heterotopia induced in rats by prenatal methylazoxymethanol treatment. Cereb Cortex (2003) 0.85